商通四海,共创未来
——海南中和药业圆满收官2025世界制药原料中国展
Hainan Zhonghe Pharmaceutical Showcases successfully
at CPHI & PMEC China 2025
亚洲领先的制药行业盛会——世界制药原料中国展(CPHI & PMEC China)于2025年6月24日至26日在上海新国际博览中心(SNIEC)隆重举办,汇聚了来自全球医药供应链各环节的供应商与采购商。
CPHI & PMEC China, Asia’s premier pharmaceutical event connecting suppliers and buyers across the entire pharmaceutical supply chain, was held from June 24–26, 2025, at Shanghai New International Expo Centre (SNIEC).
海南中和药业团队积极参与了此次享有盛誉的展会,展示了丰富的产品组合,包括原料药(API)、成品制剂以及创新的多肽类化妆品产品。
Hainan Zhonghe Pharmaceutical’s team actively participated in this prestigious exhibition, presenting a diverse portfolio including active pharmaceutical ingredients (APIs), finished dosage formulations, and innovative peptide-based cosmetics.
本届展会吸引了来自166个国家的3,500多家展商及超过90,000名专业观众,展商及观众来源包括中国、美国、印度、独联体国家、东南亚、欧洲和非洲等地区。展会面积达23万平方米,成为全球行业交流、创新与合作的重要平台。
This year’s CPHI Shanghai brought together more than 3,500 exhibitors and over 90,000 professional visitors from 166 countries, including China, United States, India, the CIS region, southeast Asia, Europe and Africa. Spanning an impressive 230,000 square meters, the exhibition served as a global hub for industry dialogue, innovation, and partnership.
在为期三天的展会期间,中和药业重点展示了其已上市和在研产品,吸引了众多国际专家和业内人士的广泛关注。展位不仅是展示产品的平台,更是深入交流、技术探讨和战略合作的桥梁。通过面对面的沟通,不仅加深了现有合作关系,还发掘了新的商业机会。这些交流也为公司洞察全球市场需求提供了宝贵信息,增强了新老客户对公司的信心。
Throughout the three-day event, Zhonghe Pharmaceutical highlighted both its commercialized and pipeline products, drawing interest from a wide range of international experts and industry stakeholders. The exhibition booth served as a platform for in-depth discussions, technical exchanges, and strategic partnership development, reinforcing existing relationships and uncovering new business opportunities. These face-to-face interactions provided valuable insights into global market demands and strengthened confidence among new and long-standing clients alike.
海南中和药业立足中国,放眼全球,将继续依托强大的产业链,不断提升产品质量与服务水平,为全球市场提供高品质的多肽类医药产品。中和药业将始终坚守初心,坚持持续创新与国际化,致力于成为全球领先的多肽类药品制造商。
Hainan Zhonghe Pharmaceutical remains firmly rooted in China with a global outlook. The company will continue to leverage its strong industrial chain, elevate product quality and service standards, and deliver high-quality pharmaceutical and peptide-based solutions to the international market. As part of its ongoing commitment to innovation and globalization, Zhonghe strives to become a world-leading manufacturer in the field of peptide pharmaceutical.
欢迎扫描二维码,浏览我们的药品、原料药及化妆品产品目录。
Please scan QR code to check our FDFs, APIs and cosmetic catalogs.